4//SEC Filing
Foundation Medicine, Inc. 4
Accession 0001209191-17-029595
CIK 0001488613operating
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:01 PM ET
Size
5.0 KB
Accession
0001209191-17-029595
Insider Transaction Report
Form 4
Daly David
Chief Commercial Officer
Transactions
- Award
Common Stock
2017-05-01$35.80/sh+24,550$878,890→ 123,132 total
Footnotes (1)
- [F1]Represents restricted stock units issued pursuant to a Restricted Stock Unit Award Agreement and the Issuer's 2013 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in equal quarterly installments over a three-year period with the first installment vesting on August 1, 2017.
Documents
Issuer
Foundation Medicine, Inc.
CIK 0001488613
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001488613
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 4:01 PM ET
- Size
- 5.0 KB